Prostate Cancer News on BioPortfolio

AZ and MSD impress at ASCO with Lynparza combo data in prostate cancer

In another major ASCO reveal AstraZeneca and partner MSD lifted the curtain at the event on new data for its poly ADPribose polymerase PARP inhibitor Lynparza olaparib in combination with J&Js standardofcare drug Zytiga abiraterone in the treatment...

LIDDS receives patent approval in Europe

The European patent office has approved LIDDS' patent related to devices and methods of injection. The patent is now approved in all major markets and provides protection for all drug formulations based on the NanoZolid technology. The patent...

Pages